Short answer · Medically reviewed summary · Last updated: 2026-04-06
The prevalence of Alagille syndrome is estimated to be between 1 in 30,000 and 1 in 50,000 live births, though these figures are likely underestimates due to historical challenges in clinical recognition. Epidemiology and Incidence Alagille syndrome is classified as a rare genetic disorder. While the estimated incidence is approximately 1 in 30,000 to 50,000, true prevalence is difficult to capture precisely.
What is the prevalence of Alagille Syndrome?
Prevalence of Alagille Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
The prevalence of Alagille syndrome is estimated to be between 1 in 30,000 and 1 in 50,000 live births, though these figures are likely underestimates due to historical challenges in clinical recognition.
Epidemiology and Incidence
Alagille syndrome is classified as a rare genetic disorder. While the estimated incidence is approximately 1 in 30,000 to 50,000, true prevalence is difficult to capture precisely. Because Alagille syndrome presents with a wide spectrum of clinical severity—ranging from mild cases that may go undiagnosed to severe multisystem involvement—many individuals likely remain undiagnosed or misdiagnosed in clinical settings. There is currently no evidence suggesting that Alagille syndrome affects males and females differently, nor are there known ethnic or geographic clusters; it appears to occur with equal frequency across diverse populations worldwide.
Age of Onset and Diagnostic Challenges
As a genetic condition typically caused by mutations in the JAG1 or NOTCH2 genes, Alagille syndrome is present from birth, with symptoms most commonly manifesting in infancy or early childhood. However, because some individuals exhibit only mild cardiac or skeletal features, they may not be identified until adulthood, making it a condition that spans the entire lifespan. The clinical diagnostic criteria have evolved, and increased awareness of the phenotypic variability of Alagille syndrome is helping to improve detection rates.
Real-World Perspectives
While formal epidemiological studies provide a baseline, patient-powered platforms offer vital insights into the lived experience of this condition. At DiseaseMaps.org, our community of 122 individuals living with Alagille syndrome provides a unique, real-world perspective on the heterogeneity of the disease. This patient-reported data complements clinical literature by highlighting the ongoing diagnostic journey and the diverse ways this syndrome impacts families globally.
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Online Mendelian Inheritance in Man (OMIM)
- Alagille Syndrome Alliance
